Vaxcell-Bio Therapeutics (323990.KQ) Earnings Analysis
Vaxcell-Bio Therapeutics (323990.KQ) has no confirmed upcoming earnings date. Trailing P/E -6.45.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 323990.KQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 323990.KQ. This page updates as the calendar is published.
323990.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-02 | -180.96 KRW | n/a | n/a | n/a |
| 2025-11-12 | -116 KRW | n/a | n/a | n/a |
| 2025-08-18 | -166.53595 KRW | n/a | n/a | n/a |
| 2025-05-15 | -113.97098 KRW | n/a | n/a | n/a |
| 2024-11-14 | -105 KRW | n/a | n/a | n/a |
| 2024-08-14 | -106.47 KRW | n/a | n/a | n/a |
323990.KQ valuation and analyst view
| Trailing P/E | -6.45 |
|---|---|
| Trailing EPS | -634.05389 KRW |
| Price / book | 1.66 |
| Dividend yield | 0.00% |
| Market cap | 89.45B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Vaxcell-Bio Therapeutics (323990.KQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 323990.KQ. This page updates as the calendar is published.
Did 323990.KQ beat earnings last quarter?
Consensus estimate data was not available for 323990.KQ's 2026-02-02 report.
What is 323990.KQ's current P/E ratio and EPS?
323990.KQ trades at a trailing P/E of -6.45 on trailing EPS of -634.0538941525002 KRW.
What do analysts rate 323990.KQ?
323990.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.